Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125962471 | 12596247 | 1 | I | 20160718 | 20160727 | 20160727 | EXP | GN-STRIDES ARCOLAB LIMITED-2016SP010244 | STRIDES | CISSE M, SOUMAH M, TOUNKARA T, DIANE B, SACK F, BALDE H, CAMARA A, CAMARA A AND DOUMBOUYA A. LYELL SYNDROME WITH FATAL OUTCOME IN TWO PREGNANT WOMEN RECEIVING ANTIRETROVIRAL THERAPY IN GUINEA CONAKRY. J COSMET DERMATOL SCI APPL. 2013;3:135-138 | 0.00 | Y | 0.00000 | 20160726 | OT | GN | GN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125962471 | 12596247 | 1 | PS | NEVIRAPINE. | NEVIRAPINE | 1 | Transplacental | MATERNAL DOSE OF 200 MG | 78195 | ||||||||||
| 125962471 | 12596247 | 2 | SS | Lamivudine and Zidovudine Tablets | LAMIVUDINEIDOVUDINE | 1 | Transplacental | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125962471 | 12596247 | HO |
| 125962471 | 12596247 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125962471 | 12596247 | Foetal exposure during pregnancy | |
| 125962471 | 12596247 | Low birth weight baby | |
| 125962471 | 12596247 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |